Cargando…
Second Malignant Neoplasms in Patients With Rhabdomyosarcoma
OBJECTIVE: Rhabdomyosarcoma (RMS) is a rare malignant tumor. The main treatment modality is comprehensive with chemotherapy, radiotherapy, and surgery. With the advancement in recent decades, patient survival has been prolonged, and long-term complications are attracting increasing attention among b...
Autores principales: | Zhen, Hongnan, Liu, Zhikai, Guan, Hui, Ma, Jiabin, Wang, Wenhui, Shen, Jing, Miao, Zheng, Zhang, Fuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553267/ https://www.ncbi.nlm.nih.gov/pubmed/34722311 http://dx.doi.org/10.3389/fonc.2021.757095 |
Ejemplares similares
-
Risk of developing second malignant neoplasms in patients with neuroblastoma: a population study of the US SEER database
por: Zhen, Hongnan, et al.
Publicado: (2021) -
Clinical analysis of EBRT vs TLM in the treatment of early (T1-T2N0) glottic laryngeal cancer
por: Shen, Jing, et al.
Publicado: (2020) -
Automatic Segmentation of Clinical Target Volumes for Post-Modified Radical Mastectomy Radiotherapy Using Convolutional Neural Networks
por: Liu, Zhikai, et al.
Publicado: (2021) -
Clinical application of radiotherapy in patients with oligometastatic ovarian cancer: a sharp tool to prolong the interval of systemic treatment
por: Shen, Jing, et al.
Publicado: (2022) -
The Impact of Different Simulation Modalities on Target Volume Delineation in Breast-Conserving Radiotherapy
por: Jin, Meng, et al.
Publicado: (2021)